153 related articles for article (PubMed ID: 8759248)
21. Stereoselective electrophysiological effects of propafenone in Langendorff perfused guinea pig hearts.
Stark U; Stark G; Stoschitzky K; Pilger E; Nagl S; Lindner W; Tritthart HA
Basic Res Cardiol; 1992; 87(1):87-97. PubMed ID: 1567355
[TBL] [Abstract][Full Text] [Related]
22. Cardiac effects of quinidine on guinea-pig isolated perfused hearts after in vivo quinidine pretreatment.
Yang Q; Padrini R; Piovan D; Ferrari M
Br J Pharmacol; 1997 Sep; 122(1):7-12. PubMed ID: 9298522
[TBL] [Abstract][Full Text] [Related]
23. Ventricular fibrillation during no-flow global ischemia in isolated rabbit hearts.
Wu TJ; Lin SF; Hsieh YC; Ting CT; Chen PS
J Cardiovasc Electrophysiol; 2006 Oct; 17(10):1112-20. PubMed ID: 16879627
[TBL] [Abstract][Full Text] [Related]
24. Frequency-dependent effects of propafenone decrease with duration of ventricular tachycardia in isolated guinea pig hearts.
Stark G; Dhein S; Bachernegg M; Ziskoven U; Zhao Y; Klaus W; Kickenweiz E; Decrinis M; Tritthart HA
Eur J Pharmacol; 1994 Feb; 252(3):283-9. PubMed ID: 8162951
[TBL] [Abstract][Full Text] [Related]
25. [Ischemic postconditioning of the myocardium: a new method of heart protection against reperfusion damage].
Shliakhto EV; Galagudza MM; Syrenskiĭ AV; Tsyrlin VA
Ter Arkh; 2005; 77(5):77-80. PubMed ID: 15989012
[TBL] [Abstract][Full Text] [Related]
26. Further investigations into the mechanism of antifibrillatory action of the specific IK1 blocker, RP58866, assessed using the rat dual coronary perfusion model.
Rees SA; Curtis MJ
J Mol Cell Cardiol; 1995 Dec; 27(12):2595-606. PubMed ID: 8825880
[TBL] [Abstract][Full Text] [Related]
27. CD59 prevents human complement-mediated injuries in isolated guinea pig hearts.
Wu S; Ma H; Huang S; Dong Y; Wu C; Shun J
Chin Med J (Engl); 2002 Feb; 115(2):175-8. PubMed ID: 11940325
[TBL] [Abstract][Full Text] [Related]
28. Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects.
Kirchhof PF; Fabritz CL; Franz MR
Circulation; 1998 Jun; 97(25):2567-74. PubMed ID: 9657478
[TBL] [Abstract][Full Text] [Related]
29. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
[TBL] [Abstract][Full Text] [Related]
30. Rate-dependent effects of ajmaline and propafenone on atrioventricular conduction.
Stark G; Schwarzl I; Stark U; Decrinis M; Tritthart HA
Eur J Pharmacol; 1996 Aug; 310(1):29-35. PubMed ID: 8880064
[TBL] [Abstract][Full Text] [Related]
31. The effect of a benzotriazinium salt on in vitro and in vivo arrhythmias in guinea-pigs and mice.
Scott NC; French AM
Arch Int Pharmacodyn Ther; 1980 Nov; 248(1):154-65. PubMed ID: 7212873
[TBL] [Abstract][Full Text] [Related]
32. Antifibrillatory effects of clofilium in the rabbit isolated heart.
Friedrichs GS; Chi L; Green AL; Lucchesi BR
Br J Pharmacol; 1994 Sep; 113(1):209-15. PubMed ID: 7812612
[TBL] [Abstract][Full Text] [Related]
33. Calcium-antagonist effects of norbormide on isolated perfused heart and cardiac myocytes of guinea-pig: a comparison with verapamil.
Bova S; Cargnelli G; D'Amato E; Forti S; Yang Q; Trevisi L; Debetto P; Cima L; Luciani S; Padrini R
Br J Pharmacol; 1997 Jan; 120(1):19-24. PubMed ID: 9117093
[TBL] [Abstract][Full Text] [Related]
34. Catecholaminergic effects on ventricular repolarization during inhibition of the rapid component of the delayed rectifier potassium current in a perfused heart model.
Overholser BR; Zheng X; Tisdale JE
Pharmacotherapy; 2008 Nov; 28(11):1315-24. PubMed ID: 18956991
[TBL] [Abstract][Full Text] [Related]
35. [Time-frequency analysis of ventricular fibrillation and the effects of amiodarone].
Wang K; Deng X; Xu Z; Li S; Liu Y; Guo R; Patwardhan A; Leonelli F
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):45-9. PubMed ID: 17333890
[TBL] [Abstract][Full Text] [Related]
36. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.
Lee JK; Klein GJ; Krahn AD; Yee R; Zarnke K; Simpson C; Skanes A; Spindler B
Am Heart J; 2000 Dec; 140(6):871-7. PubMed ID: 11099990
[TBL] [Abstract][Full Text] [Related]
37. Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination.
Biffi M; Boriani G; Bronzetti G; Capucci A; Branzi A; Magnani B
Heart; 1999 Aug; 82(2):176-82. PubMed ID: 10409531
[TBL] [Abstract][Full Text] [Related]
38. Acute anti-fibrillating and defibrillating potential of atorvastatin, melatonin, eicosapentaenoic acid and docosahexaenoic acid demonstrated in isolated heart model.
Benova T; Knezl V; Viczenczova C; Bacova BS; Radosinska J; Tribulova N
J Physiol Pharmacol; 2015 Feb; 66(1):83-9. PubMed ID: 25716968
[TBL] [Abstract][Full Text] [Related]
39. Repetitive endocardial focal discharges during ventricular fibrillation with prolonged global ischemia in isolated rabbit hearts.
Wu TJ; Lin SF; Hsieh YC; Chiu YT; Ting CT
Circ J; 2009 Oct; 73(10):1803-11. PubMed ID: 19652397
[TBL] [Abstract][Full Text] [Related]
40. Myocardial Ca2+ handling and cell-to-cell coupling, key factors in prevention of sudden cardiac death.
Tribulova N; Seki S; Radosinska J; Kaplan P; Babusikova E; Knezl V; Mochizuki S
Can J Physiol Pharmacol; 2009 Dec; 87(12):1120-9. PubMed ID: 20029549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
